C12Y 101/01201
7-beta-hydroxysteroid dehydrogenase
Official title: 7-Beta-hydroxysteroid dehydrogenase (NADP+) (1.1.1.201)
C12Y101/01201 (7-beta-hydroxysteroid dehydrogenase) appears on 11 US grants and 17 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 17
- Assignees
- 4
- Inventors
- 19
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 3 |
| 2018 | 0 | 2 |
| 2019 | 2 | 1 |
| 2020 | 3 | 2 |
| 2021 | 3 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production method of recombinant Escherichia coli and high-purity ursodeoxycholic acid12 May 2026US 12,624,335 B2Xi'an Yueda Biotechnology Co., Ltd.
- 7β-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid14 May 2024US 11,981,935 B2PharmaZell GmbH
- Coupled, self-sufficient biotransformation of chenodeoxcholic acid to ursodeoxycholic acid and novel enzyme mutants applicable in said process25 Apr 2023US 11,634,743 B2PharmaZell GmbH
- Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization14 Dec 2021US 11,197,897 B2Memorial Sloan Kettering Cancer Center
- 7-beta-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid14 Dec 2021US 11,198,896 B2PharmaZell GmbH
- 7beta-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid16 Oct 2025US 2025/0320467 A1PharmaZell GmbH
- Novel 7beta-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid18 Jul 2024US 2024/0240158 A1PharmaZell GmbH
- Production method of recombinant escherichia coli and high-purity ursodeoxycholic acid14 Sep 2023US 2023/0287333 A1Xi'an Yueda Biotechnology Co., Ltd.
- Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization31 Mar 2022US 2022/0096567 A1Memorial Sloan Kettering Cancer Center
- Novel 7beta-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid13 May 2021US 2021/0139862 A1PharmaZell GmbH
Most cited
By later US patents
- Methods and compositions for reducing vancomycin-resistant Enterococci infection or colonization3US 10,646,520 B2Memorial Sloan Kettering Cancer Center · 2020
- 7β-hydroxysteroid dehydrogenases and their use1US 10,465,171 B2PharmaZell GmbH · 2019
- Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization1US 11,197,897 B2Memorial Sloan Kettering Cancer Center · 2021